Nicolas Goossens

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi request reprint [Alcoholic steatohepatitis: what's new in 2012?]
    N Goossens
    Service de gastroentérologie et hepatologie, Département des spécialités, HUG, Geneve
    Rev Med Suisse 8:1646-8, 1650-1. 2012
  2. pmc A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
    Saskia Ditisheim
    Gastroenterology and Hepatology, University Hospitals and Faculty of Medicine, 4, rue Gabrielle Perret Gentil, 1211 Geneva, Switzerland
    BMC Gastroenterol 11:134. 2011
  3. ncbi request reprint [New treatments for hepatitis C, which targets, what timeline?]
    Nicolas Goossens
    Service de Gastroentérologie et d Hépatologie, Département des spécialités, HUG, 1211 Geneve 14
    Rev Med Suisse 7:1683-8. 2011

Collaborators

  • L Spahr
  • Saskia Ditisheim
  • Pierre R Burkhard
  • Antoine Hadengue
  • Gilles Mentha
  • Emiliano Giostra

Detail Information

Publications3

  1. ncbi request reprint [Alcoholic steatohepatitis: what's new in 2012?]
    N Goossens
    Service de gastroentérologie et hepatologie, Département des spécialités, HUG, Geneve
    Rev Med Suisse 8:1646-8, 1650-1. 2012
    ..In case of uncontrolled infection, pentoxifylline may be administered. The Lille score, measured at the 7th day of corticosteroid therapy, measures response to therapy and guides the total duration of treatment...
  2. pmc A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
    Saskia Ditisheim
    Gastroenterology and Hepatology, University Hospitals and Faculty of Medicine, 4, rue Gabrielle Perret Gentil, 1211 Geneva, Switzerland
    BMC Gastroenterol 11:134. 2011
    ..Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis. A single determination of ammonia in venous blood correlates poorly with neurological symptoms. Thus, a better biological marker is needed...
  3. ncbi request reprint [New treatments for hepatitis C, which targets, what timeline?]
    Nicolas Goossens
    Service de Gastroentérologie et d Hépatologie, Département des spécialités, HUG, 1211 Geneve 14
    Rev Med Suisse 7:1683-8. 2011
    ..However, these new molecules may lead to serious adverse effects and drug interactions with which the specialist and the primary care physician must be familiar...